SAVA
Cassava Sciences Inc
NASDAQ · Pharmaceuticals
$2.03
+0.14 (+7.41%)
Open$1.93
Previous Close$1.89
Day High$2.07
Day Low$1.92
52W High$17.77
52W Low$9.34
Volume—
Avg Volume465.6K
Market Cap98.07M
P/E Ratio19.44
EPS$0.68
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+653.7% upside
Current
$2.03
$2.03
Target
$15.30
$15.30
$10.17
$15.30 avg
$19.74
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 22.84M | 20.47M | 21.96M |
| Net Income | 4.14M | 5.17M | 4.25M |
| Profit Margin | 18.1% | 25.2% | 19.3% |
| EBITDA | 7.09M | 5.98M | 7.27M |
| Free Cash Flow | 3.09M | 2.63M | 3.14M |
| Rev Growth | -6.9% | +1.2% | +18.5% |
| Debt/Equity | 1.35 | 1.36 | 1.39 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |